Last updated on April 2018

A Retrospective Observational Study to Assess the Impact of Co-morbidities on Treatment Response in Inflammatory Bowel Disease

Brief description of study

The purpose of this study is to evaluate the impact of the co-morbidities profile on treatment response in inflammatory bowel disease (IBD) patients.

Detailed Study Description

This is a retrospective, non-interventional, observational study that will include consecutive participants diagnosed with Ulcerative Colitis (UC) or Crohn's Disease (CD) who started treatment with biologics between June 2011 and June 2013. This study will look at the impact of the co-morbidities on treatment response in IBD patients.

The study will enroll approximately 400 patients: 200 UC patients and 200 CD patients.

This multicenter trial will be conducted in Spain. Investigator will collect retrospective data in a single visit from participants who started biologic treatment between June 2011 and June 2013. Time since participants started biological treatment until study visit or until lack of treatment response or until treatment change will constitute the reference period for the study.

Clinical Study Identifier: NCT02861118

Contact Investigators or Research Sites near you

Start Over

Santiago de Compostela, Spain

Huesca, Spain

Gijon, Spain

Alcazar de San Juan, Spain

Girona, Spain

Takeda Study Registration Call Center

Las Palmas de GC, Spain

Alcorcon, Spain

Fuenlabrada, Spain

Parla, Spain

Pamplona, Spain

Vigo, Spain

Castellon de la Plana, Spain

Sagunto, Spain

Barakaldo, Spain

Barcelona, Spain

Burgos, Spain

Ciudad Real, Spain

Madrid, Spain

Murcia, Spain

Santander, Spain

Sevilla, Spain

Valencia, Spain

Valladolid, Spain

Las Palmas De GC, Spain